Supplementation With Alpha-lipoic Acid and Silybum Marianum(LUDLEV®) for the Improvement of Fatty Liver Disease

NCT05913986 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Metabolic Associated Fatty Liver Disease

Interventions

DIETARY_SUPPLEMENT: LUDLEV®300 mg/46.2 mg
OTHER: Placebo

Sponsor

Saluz Investigación S. C.